Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study.
Autoimmun Rev
; 20(2): 102726, 2021 Feb.
Article
in En
| MEDLINE
| ID: mdl-33326855
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Interleukin 1 Receptor Antagonist Protein
/
COVID-19 Drug Treatment
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Autoimmun Rev
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2021
Document type:
Article
Country of publication: